E. Bjorklund

721 total citations
9 papers, 548 citations indexed

About

E. Bjorklund is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, E. Bjorklund has authored 9 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Hematology. Recurrent topics in E. Bjorklund's work include Acute Lymphoblastic Leukemia research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). E. Bjorklund is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). E. Bjorklund collaborates with scholars based in Sweden, Netherlands and Germany. E. Bjorklund's co-authors include Joanna Mazur, Lars Wallentin, Kai C. Wollert, S Söderhäll, S.‐O. Olofsson, Tim Allhoff, Timo Peter, Bertil Lindahl, Tibor Kempf and Jörn Tongers and has published in prestigious journals such as European Heart Journal, Heart and Leukemia.

In The Last Decade

E. Bjorklund

8 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Bjorklund Sweden	7	236	203	177	173	130	9	548
Thomas Loew United States	9	206 0.9×	116 0.6×	121 0.7×	42 0.2×	340 2.6×	14	623
Georgios Paterakis Greece	10	92 0.4×	47 0.2×	15 0.1×	101 0.6×	32 0.2×	32	368
Jan Lenaerts Belgium	13	97 0.4×	20 0.1×	354 2.0×	238 1.4×	66 0.5×	36	622
James W. Behan United States	9	120 0.5×	112 0.6×	12 0.1×	62 0.4×	70 0.5×	13	529
Bernadette Heizel M. Reyes Philippines	7	98 0.4×	50 0.2×	168 0.9×	102 0.6×	14 0.1×	12	395
Kumiko Shimoyama Japan	11	62 0.3×	19 0.1×	92 0.5×	70 0.4×	91 0.7×	30	342
Pierluigi Marradi Italy	12	103 0.4×	53 0.3×	35 0.2×	19 0.1×	48 0.4×	22	377
Evripidis Kaltsonoudis Greece	11	67 0.3×	41 0.2×	230 1.3×	156 0.9×	17 0.1×	25	426
D Loukopoulos Greece	12	153 0.6×	14 0.1×	52 0.3×	50 0.3×	42 0.3×	27	366
Dorthe Rønnov‐Jessen Denmark	9	293 1.2×	25 0.1×	80 0.5×	46 0.3×	94 0.7×	14	465

Countries citing papers authored by E. Bjorklund

Since Specialization

Citations

This map shows the geographic impact of E. Bjorklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bjorklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bjorklund more than expected).

Fields of papers citing papers by E. Bjorklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Bjorklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bjorklund. The network helps show where E. Bjorklund may publish in the future.

Co-authorship network of co-authors of E. Bjorklund

This figure shows the co-authorship network connecting the top 25 collaborators of E. Bjorklund. A scholar is included among the top collaborators of E. Bjorklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bjorklund. E. Bjorklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Zhang, Jie, Sara S. Rinne, E. Bjorklund, et al.. (2024). Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts. ACS Pharmacology & Translational Science. 7(10). 3228–3240. 2 indexed citations

Hjalmarsson, Clara, Göran Rådegran, E. Bjorklund, et al.. (2024). Prognostic Significance of Positive Vasoreactivity Test in Pulmonary Arterial Hypertension is Affected by Age. The Journal of Heart and Lung Transplantation. 43(4). S407–S407.

Bjorklund, E., et al.. (2009). Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia. Haematologica. 94(7). 1016–1019. 80 indexed citations

Kempf, Tibor, E. Bjorklund, S.‐O. Olofsson, et al.. (2007). Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. European Heart Journal. 28(23). 2858–2865. 189 indexed citations

Bjorklund, E., et al.. (2005). Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Heart. 92(6). 735–740. 27 indexed citations

Pérez‐Andrés, Martín, M. de Jesús Gallegos Santiago, Júlio César Franco Almeida, et al.. (2005). Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathies.. PubMed. 18(3-4). 392–8. 8 indexed citations

Malec, M, Vincent H. J. van der Velden, E. Bjorklund, et al.. (2004). Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping. Leukemia. 18(10). 1630–1636. 58 indexed citations

Bergström, C, et al.. (2003). Lack of donors limits the use of islet transplantation as treatment for diabetes. Transplantation Proceedings. 35(2). 764–764. 11 indexed citations

Lúcio, Paulo, A Parreira, ER van Wering, et al.. (1999). Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia. 13(3). 419–427. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact